Penetrating Aortic Ulcer (PAU): Evidence‑Based Diagnosis, Management, and Follow‑up
Epidemiology & Risk Factors
Older age, male sex, tobacco use, hypertension, and hyperlipidaemia are the principal risk factors for PAU in patients with atherosclerotic disease. 1, 2, 3 – European Society of Cardiology (ESC) guideline.
PAU predominantly affects the distal (mid‑ to distal third) descending thoracic aorta and is uncommon in younger individuals; it rarely presents with organ malperfusion, distinguishing it from classic aortic dissection. 1, 2, 3 – ESC.
Clinical Presentation
- The onset of pain in an at‑risk patient should be considered an emergency because the ulcer often reaches the adventitia, placing the patient at imminent risk of aortic rupture. 1, 2 – ESC.
Diagnostic Imaging
Contrast‑enhanced computed tomography (CT) with axial and multiplanar reformations is the imaging modality of choice for confirming PAU. 1, 2, 3 – ESC.
Typical CT findings include a focal ulcer penetrating the intima through a calcified atherosclerotic plaque, often accompanied by dislodged intimal calcifications that are not visualised on MRI. 1, 2 – ESC.
Adjacent focal aortic wall thickening or high attenuation on CT suggests an associated intramural hematoma (IMH). 1, 2 – ESC.
Unenhanced CT may mimic IMH; therefore, intravenous contrast is essential to differentiate PAU from isolated IMH. 2, 3 – ESC.
Initial Medical Management
- All patients should receive immediate medical therapy comprising aggressive analgesia and strict blood‑pressure control (target systolic <120 mm Hg and heart‑rate ≤60 bpm) irrespective of subsequent invasive planning. 1, 2, 3 – ESC.
Indications for Invasive Intervention
Intervention is warranted when any of the following are present:
Size thresholds alone (e.g., ulcer diameter > 20 mm or neck > 10 mm) are not universally accepted as decisive criteria; clinical presentation and imaging instability should guide treatment decisions. 1, 2, 3 – ESC.
Preferred Revascularisation Strategy
Thoracic endovascular aortic repair (TEVAR) is the preferred therapeutic approach for most PAU patients, who are often poor candidates for open surgery due to advanced age and comorbidities. 1, 2, 3 – ESC.
No randomized controlled trials have compared TEVAR with open surgical repair for PAU, so treatment selection relies on anatomical suitability, clinical status, and patient comorbidities. 1, 2 – ESC.
Surveillance Protocol
Patients managed conservatively require scheduled imaging follow‑up with contrast‑enhanced CT or magnetic resonance angiography (MRA) to monitor for lesion progression. 1, 2, 4 – ESC (and American Heart Association (AHA)/American College of Cardiology (ACC) for the Circulation reference).
Close surveillance is especially important in individuals with aortic dilation or ulcer‑like projections, as they have a higher risk of late complications. 1, 3 – ESC.
Long‑term complications may include conversion to classic dissection, further aortic enlargement, and development of saccular aneurysms. 4 – AHA/ACC.
Critical Pitfalls to Avoid
Do not dismiss pain in elderly patients with atherosclerotic risk factors; PAU can rapidly progress to rupture. 1, 2 – ESC.
Do not rely solely on MRI for diagnosis, because it cannot detect the characteristic intimal calcification dislodgement seen on CT. 1, 2 – ESC.
Do not postpone intervention in symptomatic patients or when imaging shows signs of contained rupture. 1, 2, 3 – ESC.
Do not base the decision to intervene solely on ulcer size; prioritize symptoms and imaging markers of instability. 1, 2, 3 – ESC.
Long‑Term Medical Therapy
- Aggressive modification of cardiovascular risk factors is essential for secondary prevention: smoking cessation, lipid‑lowering therapy aiming for ≥50 % LDL‑C reduction, low‑dose aspirin, and stringent blood‑pressure and heart‑rate control. Smoking cessation is specifically recommended. 1, 2 – ESC.
Clinical Significance of Thoracic Aortic Tortuosity and Atherosclerotic Changes
Atherosclerotic Changes: Direct Clinical Impact
- Atherosclerosis is the primary cause of thoracic aortic aneurysms, with severe atherosclerosis involving more than 70% of the aortic surface in over 90% of patients with aneurysms 5
- The pathophysiology involves intimal thickening with massive fibrosis and calcification, which compromises nutrient supply to the media, resulting in medial thinning and increased vessel stiffness 5
- Fusiform thoracic aortic aneurysms have a 61% rupture risk, significantly higher than abdominal aortic aneurysms 5
- Hypertension is present in 85% of patients with ruptured aneurysms, making it the dominant modifiable risk factor 5
Penetrating Aortic Ulcer Development
- Atherosclerotic plaques can ulcerate and penetrate the internal elastic lamina, creating penetrating aortic ulcers (PAU) with rupture risk as high as 33-75% when complicated by intramural hematoma 6
- PAU typically affects older males (>65 years) with multiple comorbidities including hypertension, coronary artery disease, COPD, and renal insufficiency 6
- High-risk imaging features requiring intervention include maximum PAU width ≥13-20 mm, depth ≥10 mm, or growth >5 mm/year 6
Tortuosity: Procedural and Prognostic Implications
- Increased aortic tortuosity in the proximal landing zone is independently associated with higher risk of endoleak, stroke, and all-cause mortality after TEVAR 7, 8
- Patients with high tortuosity index have significantly elevated rates of type III endoleaks, particularly when tortuosity affects both the proximal fixation zone and diseased segment 7, 8
Clinical Management Implications
- Quantitative assessment of aortic tortuosity using CT angiography should be performed before TEVAR to identify high-risk patients requiring enhanced procedural planning and postoperative surveillance 7, 8
- Assessment must include iliofemoral artery diameters, calcification extent, and tortuosity for complete TEVAR planning 7, 8
- ECG-gated CT is particularly important for ascending aorta measurements, as 5-10% diameter variation occurs between systole and diastole 7, 8
- For patients with aortic atherosclerosis, LDL-C reduction by ≥50% from baseline with goal <55 mg/dL is recommended 6
- Low-dose aspirin (75-162 mg/day) should be used to reduce cardiovascular event risk 6
- Strict blood pressure control (systolic <120 mmHg) and heart rate control (≤60 bpm) are essential, particularly in penetrating aortic ulcer 6
- Patients with identified tortuosity and atherosclerotic changes require closer imaging follow-up to screen for late-developing complications, particularly endoleak after TEVAR 7, 8